Press "Enter" to skip to content

New patent expiration for Clovis Oncology drug RUBRACA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Clovis Oncology drug RUBRACA

Annual Drug Patent Expirations for RUBRACA
Annual Drug Patent Expirations for RUBRACA

Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug.

This drug has two hundred and forty-three patent family members in fifty-three countries.

The generic ingredient in RUBRACA is rucaparib camsylate. One supplier is listed for this compound. Additional details are available on the rucaparib camsylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Clovis Oncology drug RUBRACA
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions